Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
26
0
2

Year Published

2007
2007
2016
2016

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 41 publications
(29 citation statements)
references
References 14 publications
1
26
0
2
Order By: Relevance
“…(9) In addition, respiratory subtype patients have been shown to respond earlier to treatment with nortriptyline (a second-generation tricyclic antidepressant) than do non-respiratory subtype patients, the former presenting a response after only 8 weeks, although both groups had improved equally after 52 weeks. (57) Similar behavior has been observed for the high-potency benzodiazepine clonazepam. (58) …”
Section: Pharmacologic Implicationssupporting
confidence: 65%
“…(9) In addition, respiratory subtype patients have been shown to respond earlier to treatment with nortriptyline (a second-generation tricyclic antidepressant) than do non-respiratory subtype patients, the former presenting a response after only 8 weeks, although both groups had improved equally after 52 weeks. (57) Similar behavior has been observed for the high-potency benzodiazepine clonazepam. (58) …”
Section: Pharmacologic Implicationssupporting
confidence: 65%
“…The respiratory subtype of panic has a specific profile of pharmacological sensitivity, it is associated with familial risk of PD, and it may predict a greater severity of illness (Briggs et al (1993); Nardi et al, 2003Nardi et al, , 2006aBiber and Alkin, 1999;Onur et al, 2006). Epidemiological studies indicate that the presence of respiratory disorders, such as COPD (Goodwin and Pine, 2002), increases the likelihood of developing PD.…”
Section: Discussionmentioning
confidence: 99%
“…Briggs et al (1993) demonstrated that patients with the respiratory subtype of panic suffer more spontaneous PAs than patients with the residual subtype and that they respond better to imipramine than to alprazolam. The respiratory subtype has been shown to be associated with increased familial risk of PD (Horwath et al, 1997;Nardi et al, 2003Nardi et al, , 2006a, to be more common among heavy smokers, to have a longer duration and major severity of illness (Biber and Alkin, 1999), and to have a lower resting end-tidal pCO 2 (Moynihan and Gevirtz, 2001) and a higher sensitivity to CO 2 inhalation (Biber and Alkin, 1999;Valenca et al, 2002;Abrams et al, 2006;Nardi et al, 2006a, b). Other clinical features displayed by PD patients with the respiratory subtype include a later onset of the disease and a faster response to nortriptyline (Nardi et al, 2003(Nardi et al, , 2006a, more past traumatic suffocation experiences and respiratory diseases (Bouwer and Stein, 1997;Verburg et al, 1995), higher levels of anxiety sensitivity, and more panic-agoraphobic spectrum symptoms (Onur et al, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…remain symptomatic and this proportion may be higher in the naturalistic setting (9). In addition, the subtype of panic disorder (respiratory or non-respiratory) can influence the response to pharmacotherapy and affect outcomes (10)(11)(12). Furthermore, discontinuation of pharmacotherapy can lead to withdrawal symptoms and a significant number of panic disorder patients suffer relapse flowing cessation of treatment (13,14).…”
Section: Introductionmentioning
confidence: 99%